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Background: Health systems evidence can enhance policymaking and strengthen national health systems. In the
Middle East, limited research exists on the use of evidence in the policymaking process. This multi-country study
explored policymakers’ views and practices regarding the use of health systems evidence in health policymaking in
10 eastern Mediterranean countries, including factors that influence health policymaking and barriers and facilitators
to the use of evidence.
Methods: This study utilized a survey adapted and customized from a similar tool developed in Canada. Health
policymakers from 10 countries (Algeria, Bahrain, Jordan, Lebanon Oman, Pakistan, Palestine, Sudan, Tunisia, and
Yemen) were surveyed. Descriptive and bi-variate analyses were performed for quantitative questions and thematic
analysis was done for qualitative questions.
Results: A total of 237 policymakers completed the survey (56.3% response rate). Governing parties, limited funding
for the health sector and donor organizations exerted a strong influence on policymaking processes. Most (88.5%)
policymakers reported requesting evidence and 43.1% reported collaborating with researchers. Overall, 40.1%
reported that research evidence is not delivered at the right time. Lack of an explicit budget for evidence-informed
health policymaking (55.3%), lack of an administrative structure for supporting evidence-informed health
policymaking processes (52.6%), and limited value given to research (35.9%) all limited the use of research evidence.
Barriers to the use of evidence included lack of research targeting health policy, lack of funding and investments,
and political forces. Facilitators included availability of health research and research institutions, qualified
researchers, research funding, and easy access to information.
Conclusions: Health policymakers in several countries recognize the importance of using health systems evidence.
Study findings are important in light of changes unfolding in some Arab countries and can help undertake an
analysis of underlying transformations and their respective health policy implications including the way evidence
will be used in policy decisions.
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Health systems evidence can enhance policymaking and
strengthen national health systems by identifying prior-
ities, providing broader choice of policy options, inform-
ing policy formulation and implementation, and setting
the stage for evaluating the outcomes of policies [1-3].
The Bamako Call to Action, issued at the Global Minis-
terial Forum on Research for Health in November 2008,
urged national governments and international funders to
promote knowledge translation (KT) and exchange
through the application of effective and safe interven-
tions, evidence- informed policies, policy- informed re-
search, and effective dissemination of research results for
improving health systems performance [4]. This call to
action has emphasized the importance of the use of evi-
dence in policymaking and pushed KT to the spotlight in
many countries [4]. The Montreux Statement at the First
Global Symposium on Health Systems Research held in
November 2010 reinforced the need for strengthening
health systems research and enhancing its translation
into policy [5].
One of the primary challenges facing countries in their
KT and exchange initiatives is developing effective strat-
egies to promote the use and application of research in
policymaking [6]. The literature shows that the success
of KT strategies is highly dependent on tailoring the ap-
proach to the barriers and facilitators found within a
particular and unique setting [6-8]. The available litera-
ture attests to the wide gap between the “push” and
“pull,” which is also known as the “knowledge- to- action
gap”. Reasons for this gap vary across countries and are
mainly attributed to lack of interaction between policy-
makers and researchers, lack of timeliness or relevance
of research, mutual mistrust, policymakers’ lack of skills
and negative attitudes towards research, political in-
stability, as well as power and budget struggles
[1,2,6,9,10].
The application of health systems evidence in policy is
a problem faced by many developed and developing
countries. However, it is of particular concern in coun-
tries where health systems are in a state of rapid transi-
tion such as in several Middle Eastern countries. In this
region, there are greater policy concerns related to
health systems functioning, a wider range of pressing
health systems challenges, greater demands on policy-
makers to be transparent, and an emerging role for non-
state actors [3]. Addressing policy concerns and health
systems challenges is highly dependent on supporting
the use of health systems evidence in policymaking. In
the East Mediterranean region (EMR), policymakers
recognize the need for evidence for policymaking in
health systems and evidence- informed policymaking is
now garnering greater attention within the health policy
environment [3].There is a deficiency in health systems research and
systematic reviews from the EMR [3,11]. A recent print
media analysis in 44 Low and Middle Income Countries
(LMICs) which included several countries from the
EMR showed that the region is among the lowest in
terms of the articles that describe or use health systems
research [12]. The EMR has the second lowest propor-
tion (after Africa) of scientific publications addressing
health topics in the world (0.8% among all World Health
Organization (WHO) regions) [13]. The administrative
structures of several countries in the region are crippled
by poorly arranged health care systems, which affect
health care financing and delivery. This has lead to lack
of coordination where several countries face challenges
pertaining to poor resource allocation, poor public-
private partnerships, and a lack of policies for financial
sustainability, which are reflected in poor quality and in-
efficiency [14]. In a recent priority- setting exercise con-
ducted with policymakers and researchers from the
region, participants called for further exploration of
health systems research into policy, engaging policy-
makers in health systems research, and conducting sur-
veys to better understand the policymaking context and
design effective KT strategies for the region [3].
In general, most of the evidence base on KT strategies
comes from developed countries [1,2,6,9]. Only a few
studies explored the use of evidence in policymaking in
LMICs [15-19]. The few studies from LMICs show that
these countries face a unique set of challenges in pro-
moting KT due to scarce resources (financial and human
resources), weakness in health information and delivery,
lack of access to research, and corruption [15-23].
In the Middle East region, limited research exists on
the use of evidence and contributing factors in the pol-
icymaking process [3,19,23-26]. We are not aware of a
survey having been conducted about the views and prac-
tices of policymakers on the use of health systems evi-
dence in policymaking in the Middle East. The objective
of this study is to explore the views and practices of pol-
icymakers from 10 Middle Eastern countries regarding
the use of health systems evidence in health policy-
making. In addition, it aims to elucidate the factors that
influence health policymaking and the barriers and facil-
itators to the use of evidence in the policymaking
process. This multi-country study was conducted in 10
Eastern Mediterranean countries selected based on their
interest and participation in the launch meeting of the
Evidence Informed Policy Network- Eastern Mediterra-
nean Region (EVIPNet EMR), which is a social network
that encourages the use of evidence in the policymaking
process and includes researchers, policymakers and civil
society members from the EMR. Surveyed countries are
Algeria, Bahrain, Jordan, Lebanon, Oman, Pakistan, Pal-
estine, Sudan, Tunisia, and Yemen.
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A cross- sectional survey was distributed to policy-
makers in 10 countries in the Middle East region from
January 2010 to September 2010. Details on sampling of
respondents are detailed subsequently herewith. The
survey was adapted and customized from a similar tool
developed in Canada [27]; some items were rephrased,
edited or removed to fit the context of health policy-
making in the region. It consisted of a demographics
section, two quantitative scales, and open-ended ques-
tions. Demographics included questions on age, gender,
and degree. The first scale included 14 items that
assessed the policymaking context using a five- point
scale. The second scale included 16 items on a five-
point scale that assessed policymakers’ views and their
own practices in the use of evidence in policymaking.
The Likert scale was graded on a 5-point likert scale
ranging from (in ascending order of scores) strongly
agree to agree, neither agree nor disagree, disagree, to
strongly disagree. In the open-ended sections, respon-
dents were asked to list the top three factors that
exerted the strongest influence in the policymaking
process in their respective countries or organizations.
They were also asked to provide examples on: (i) the for-
mulation of a policy where evidence was available and
had an important role; (ii) where evidence was available
but was not used, and (iii) where evidence was not avail-
able but was needed. In addition, respondents were also
asked to list at least three major barriers and facilitators
to the use of evidence in policymaking and three major
suggestions to improve the use of evidence in policy-
making. Finally, they were asked to list key training
needs. The survey was originally developed in English
and translated to Arabic by a professional translator.
The survey was back-translated to English, minimal dif-
ferences were detected. It was pilot- tested and further
modified to fit the context of the region.
Institutional review board (IRB) approval was obtained
prior to data collection from the American University of
Beirut (AUB). Focal people in study countries validated
lists of potential respondents developed by the research
team. They mailed out the surveys (that were placed in
sealed envelopes) to the mailing addresses of potential
respondents in their countries. They were provided with
a detailed procedures manual which included informa-
tion on how to contact the respondents by telephone or
by email, and instructions on how to follow up with
respondents, and obtain the completed surveys. Focal
people provided respondents with sealed packages that
included:
 A sheet with instructions to respondents on how to
fill the survey, this included information on how to
contact the focal person when the survey wascomplete. Respondents were also given the option of
returning the survey directly to the research team
via courier in case they did not want to send it back
through the focal person, or faced any difficulty
doing so.
 An information sheet about the project including
study objectives, briefing on methodology and
expected benefits of study findings.
 The survey which included a consent form on the
first page. It is worth noting that although the first
page of the survey included a consent form, it did
not ask respondents to specify or sign their name.
Respondents were only asked to tick a box that
indicated that they have read and understood the
consent form, provide the researchers with
permission to use their responses and understand
that their names will not be linked to research
findings. The consent form reiterated the
explanation of the research project and its
objectives. The consent form also included
information on how to contact the AUB IRB office
(email and phone number in addition to the
protocol number for the study) in case of any
breaches of ethical protocol or even a concern about
the survey. Kindly note that no one has contacted
AUB IRB regarding any breaches to ethical protocol.
 An empty envelope to return the completed survey
was also included. To maintain the anonymity and
confidentiality of respondents, they were asked to
place the completed survey in the return envelope,
seal it then scratch on the seal before returning to
the focal people; this information was available in
the instruction sheet.
Upon completion of the survey, respondents contacted
the focal people to collect the sealed envelopes and re-
turn them to the research team in Beirut via the courier
that was contracted to do so. Although the research
team provided the focal people with the list of potential
respondents, they were not asked to specify which of the
respondents completed the survey as this would pose a
breach of ethics as well. The research team was only
provided with the total number of respondents and
number of surveys distributed in each study country.
Purposive sampling was conducted. Countries were
selected from the Middle East region based on their
interest and participation in the launch meeting of the
EVIPNet EMR that took place in January 2009. EVIPNet
EMR members were asked to act as focal persons for
this study and coordinate activities at the country level
including selection of respondents and facilitating the
administration of the survey.
A sampling frame was established to determine the se-
lection criteria for respondents from these countries. The
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Canada [27]. The sampling frame included policymakers
from different settings, defined as those who are respon-
sible for health policy decisions, strategy and planning, at
the national level, such as senior officials from the minis-
try of health (MOH) and other health- related ministries,
as well as managers in non- governmental organizations
(NGOs), professional associations, and donor agencies.
The sampling frame included four main role categories
and the descriptive positions corresponding to each of
these categories as well as specific examples on these
positions. The first category was directors in the MOH
and the corresponding positions for this category
included: minister of health or deputy minister/ under-
secretary/ secretary general, advisors and members of
councils, as well as heads of financial and administrative
affairs, policy and planning, human resources, pharma-
ceuticals and laboratories, primary healthcare, public
health program, and infectious disease program. The sec-
ond category was directors in other health- related min-
istries such as the ministry of education, ministry of
finance, and ministry of labor. The third category was
managers in NGOs and the corresponding descriptive
positions included: most senior managers/ directors in
international and national NGOs. The fourth category
was staff/ members of a health professional association
and the corresponding positions included: most senior
managers/ directors in national medical associations, na-
tional nursing associations, national pharmacists' associa-
tions, and national hospital associations. A similar
sampling frame was used for identifying policymakers
and stakeholders from the region in other studies [3,28].
The names and contact information of policymakers and
stakeholders who fit these specific categories and posi-
tions were retrieved and aggregated by the research team
based on a thorough internet search of the Ministry of
Health websites, professional associations, NGOs, and
donor agencies. The aggregated sampling frame for each
country was subsequently sent to the corresponding focal
person for validation and completion of missing informa-
tion and positions. Focal people were then requested to
send surveys to the policymakers and stakeholders on
the validated sampling frame. A procedures manual was
developed and distributed to focal people to ensure stan-
dardized data collection across countries. Respondents
were asked to complete the survey and return it to the
research team within two weeks. Respondents who had
not completed the survey within allotted time were con-
tacted twice for follow- up; once after two weeks of re-
ceiving the survey and again a week after the last contact.
To obtain a holistic perspective of the health policy-
making process and the role of evidence in policymaking
in the region, a target was initially set to survey around
25 policymakers from each country.Data was entered using CSPro 4.0 and analyzed using
the Statistical Package for Social Sciences (SPSS) 19.0
(significance level of 0.05). Descriptive analysis was per-
formed for closed-ended questions (including demo-
graphics). The uppermost and lowermost ends of the
scales were combined for the purpose of descriptive ana-
lysis i.e., strongly agree with agree and strongly disagree
with disagree. Histograms indicated that all items were
normally distributed. A one-sample t-test was used to
compare responses in each country to the overall item
mean. Moreover, t-test and ANOVA using Bonferroni
multiple F contrast was used to compare responses by
respondent affiliation. To compare respondents, they
were first broken down into two groups: Government
affiliated (i.e. respondents from the MOH) and non-
Government affiliated (i.e. respondents from NGOs,
professional associations, and donor agencies). These
two groups were analyzed using an independent sample
t-test. Respondents in non-Government affiliated organi-
zations were analyzed separately as well to account for
the specificities pertaining to each of the three settings.
These groups were analyzed using ANOVA.
Thematic analysis was used for the qualitative compo-
nent of the survey. Responses were broken into similar
concepts and ideas (open coding). Axial coding followed
in which concepts were organized into themes [29]. Re-
curring themes and emerging patterns across respon-
dents from study countries were then analyzed. Analysis
was conducted by two members of the research team
with a high level of agreement between the two. Dis-
agreements were discussed until consensus was
achieved.
Results
A total of 421 policymakers were requested to complete
the survey, of these, 237 responded (response rate
56.3%). Overall, 51.7% of respondents indicated having a
master’s degree. Many respondents (68.8%) worked as
policymakers in the MOH while 15.8% worked in NGOs,
8.1% in professional associations, and 8% in donor agen-
cies (Table 1). A total of 62.6% of respondents indicated
that they have had training in health policy (Table 1).
Factors that influence health policymaking
The majority of policymakers (74.9%) reported that lack
of coordination across different ministries and between
the government and health providers hindered the
health policymaking process (65.2%). Overall, 79.2% of
respondents reported that limited public funding for the
health sector, and the agendas of donor organizations
(72.5%), values of the governing parties (53.9%) and re-
search about problems related to healthcare or health
systems (45.5%) exerted a strong influence on the policy-
making process (Table 2).








Pakistan 42 (17.7%) 50 84.0%
Sudan 29 (12.2%) 37 78.4%
Palestine 28 (11.8%) 37 75.7%
Jordan 27 (11.4%) 34 79.4%
Yemen 27 (11.4%) 36 75.0%
Oman 23 (9.7%) 49 46.9%
Algeria 22 (9.3%) 49 44.9%
Lebanon 20 (8.4%) 24 83.3%
Bahrain 10 (4.2%) 55 18.2%
Tunisia 9 (3.8%) 50 18.0%
Total 237 421 56.3%





MD or similar 99 (41.8%)
BS/BA/BSN 52 (21.9%)
PhD or DPH 40 (16.9%)
other degree 11 (4.6%)






Donor agencies 19 (8.1%)
Respondents received training in health policy
Yes 144 (62.6%)
No 86 (37.4%)
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further confirmed that health funding and resources,
values of governing political parties and political inter-
ests of policymakers, and donor organizations and inter-
national organizations (e.g., WHO and UNICEF), as well
as availability of both national and international research
are the top factors that influenced health policymaking
processes in the region.
Policymakers’ views and practices on the use of evidence
Most respondents (88.5%) reported looking or asking
for scientific evidence to support the formulation and
implementation of health policies. Around half of the
respondents (53%) reported receiving training to
acquire scientific evidence, assess its quality and local
applicability, and apply it in health policymaking.Many respondents (69.7%) indicated participating with
researchers to identify high-priority policy issues for
which research is needed and less than half of them
(43.1%) reported that contact and collaborative rela-
tions between researchers and health policymakers
exist in their respective organizations (Table 2).
Most respondents (78.7%) indicated that they have ac-
cess to health research through an internet connection
at their respective organizations. Less than half of the
respondents (47.9%) reported that there are clearly iden-
tified places to find or to ask for scientific evidence, and
41.6% stated that there is sufficient quantity of health re-
search and that it provides sufficient information on the
impacts and costs of policies (39.1%). Less than half of
the respondents (42.9%) reported that research is not
delivered at the right time, lacks information about its
quality and local applicability (40.1%), and lacks action-
able messages (35.5%) (Table 2).
Around half of the respondents (52.1%) indicated
using evidence whenever it is available and supplied to
them while 48.5% specifically request it for the policy-
making process. More than half of respondents (55.3%)
indicated that support for evidence- informed policy-
making in their respective countries or organizations
was limited due to lack of an explicit budget for
evidence- informed health policymaking, and lack of an
administrative structure (52.6%). Moreover, 35.9% of
respondents reported that limited value is given to evi-
dence by political actors (Table 2).
Comparing responses by study countries
Below are the results of the one-sample t-test to com-
pare country means to overall item means. Items com-
prise two scales, the first on factors influencing the
policymaking process, and the second on the use of evi-
dence in the policymaking process.
Factors influencing policymaking process
Results of the comparison of means with regard to fac-
tors influencing the policymaking process are detailed in
Table 3. Compared to other countries, Yemen was found
to face several challenges with the factors influencing
the health policymaking process. One such challenge
was lack of coordination in government/ministerial rela-
tions across different ministries. In addition, physician,
nursing and other associations did not appear to have
significant influence on the health policymaking process
as compared to other countries. The influence of private
providers and insurers on the policymaking process was
also minimal (Table 3).
Jordan is another country facing slightly similar chal-
lenges in the factors influencing the policymaking
process. However, the challenge of lack of coordination
was more in government/health provider relations.









1-Lack of coordination in governmental/ministerial
relations across different ministries
(such as the Ministry of Health, Ministry of Finance, etc.)
hindered the health policymaking process.
31 (13.2%) 28 (11.9%) 176 (74.9%)
2-Lack of coordination in government/ health provider relations
hindered the health policymaking process.
44 (18.9%) 37 (15.9%) 152 (65.2%)
3-Physician associations exerted a strong influence on
the health policymaking process.
117 (50.4%) 56 (24.1%) 59 (25.4%)
4-Nursing associations exerted a strong influence on
the health policymaking process.
146 (63.8%) 63 (27.5%) 20 (8.7%)
5-Other types of health professional associations exerted a
strong influence on the health policymaking process
(e.g., Syndicate of hospitals).
115 (49.4%) 66 (28.3%) 52 (22.3%)
6-Private health providers exerted a strong influence on
the health policymaking process.
91 (39.6%) 61 (26.5%) 78 (33.9%)
7-Private insurers exerted a strong influence on
the health policymaking process.
120 (54.8%) 62 (28.3%) 37 (16.9%)
8-Values of governing parties exerted a strong influence on
the health policymaking process.
58 (25%) 49 (21.1%) 125 (53.9%)
9-Public opinion exerted a strong influence on
the health policymaking process.
78 (33.2%) 64 (27.2%) 93 (39.6%)
10-Media exerted a strong influence on the health
policymaking process.
56 (23.8%) 81 (34.5%) 98 (41.7%)
11-Research about problems related to healthcare or health
systems exerted a strong influence on the
health policymaking process.
74 (31.5%) 54 (23%) 107 (45.5%)
12-Limited public funding for health exerted a strong influence
on the health policymaking process.
31 (13.1%) 18 (7.6%) 187 (79.2%)
13-Other countries’ health policies exerted a strong influence on
the health policymaking process.
60 (25.6%) 78 (33.3%) 96 (41%)
14-Donor organizations (e.g., United States Agency for I
nternational Development (USAID), United Nations,
World Bank, World Health Organization (WHO))
exerted a strong influence on the health policymaking process.
25 (10.6%) 40 (16.9%) 171 (72.5%)
Views and practices on the use of evidence
1-I generally look and/or ask for scientific evidence to
support my work in formulating and implementing health policies.
9 (3.8%) 18 (7.7%) 208 (88.5%)
2-I have access to health research through an internet
connection at my organization.
29 (12.3%) 21 (8.9%) 185 (78.7%)
3-There are contact and collaborative relations between
researchers and health
policymakers/ decision makers in my organization.
68 (29.3%) 64 (27.6%) 100 (43.1%)
4-I participated in meetings with researchers to identify high-priority
policy issues for which research is needed to inform
how to address these issues.
34 (14.5%) 37 (15.8%) 163 (69.7%)
5-Health policymakers request scientific evidence
in the policymaking process.
66 (28.1%) 55 (23.4%) 114 (48.5%)
6-The scientific evidence is delivered at the right time. 99 (42.9%) 68 (29.4%) 64 (27.7%)
7-There are summaries of evidence with messages that
specify possible actions about health policies
issues I confronted in my organization.
83 (35.5%) 69 (29.5%) 82 (35.0%)
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Table 2 Factors that influence health policymaking and views and practices on the use of evidence in the region
(Continued)
8-The available scientific evidence provides sufficient
information on the impacts,
costs and concrete benefits of the studied or
soon-to-implement health policies.
75 (32.2%) 67 (28.8%) 91 (39.1%)
9-The available scientific evidence is delivered with
information about its quality and local applicability.
93 (40.1%) 67 (28.9%) 72 (31.0%)
10-There is a sufficient quantity of health research that
may contribute to inform the
health policymaking/decision making process.
85 (36.8%) 50 (21.6%) 96 (41.6%)
11-There are clearly identified places to find or to ask
for scientific evidence that may
inform the health policymaking/decision making process.
78 (33.3%) 44 (18.8%) 112 (47.9%)
12-Health policymakers use scientific evidence in the
policymaking process
whenever it is available and supplied to them.
56 (23.9%) 56 (23.9%) 122 (52.1%)
13-I have received training to acquire, assess the quality
and local applicability of scientific evidence, and apply
scientific evidence in health policymaking/decision making.
76 (32.5%) 34 (14.5%) 124 (53%)
14-There is explicit budget or funding for both research and
evidence- informed health policymaking
within my organization.
130 (55.3%) 47 (20%) 58 (24.7%)
15-There is an administrative structure suitable to support an
evidence- informed health policymaking process
(for example; a policy analysis department or a decision
support unit, or the availability of resources, incentives and time
for the use of scientific evidence in health policymaking).
123 (52.6%) 45 (19.2%) 66 (28.2%)
16-The political actors related with health (political parties,
ministers, parliament,
other ministries, etc.) value the use of scientific
evidence in the policymaking process.
84 (35.9%) 83 (35.5%) 67 (28.6%)
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the policymaking process in Jordan, it was significantly
better as compared to the overall mean and to other
countries as well. While results showed that Jordan fared
slightly better than Oman with regard to the influence of
the values of governing parties on the policymaking
process, this influence was still not as highly pronounced
as compared to Sudan. However, the influence of the media
on the policymaking was significantly better than the over-
all mean and in relation to other countries (Table 3).
If we also consider the case of Oman, the lack of coord-
ination in government and ministerial and health provider
relations did not pose as much of a challenge as com-
pared other countries. The influence of private providers
and values governing parties also didn’t appear to pose a
challenge for Oman as compared to other countries.
However, the influence of research about problems related
to healthcare did appear to have a stronger influence on
the health policymaking process in Oman as compared to
the overall mean and other countries as well (Table 3).
Use of evidence in the health policymaking process
Results of the comparison of means on items describing
the use of evidence in the policymaking process aredetailed in Table 3. Yemen also emerged as a country fa-
cing challenges with use of evidence in the policymaking
process. Specifically, and compared to other countries,
policymakers in Yemen reported having much fewer
contacts and collaboration between researchers and
health policymakers. Moreover, in Yemen, scientific evi-
dence is not delivered at the right time and lacks infor-
mation on quality and local applicability. Additionally,
summaries of evidence with messages specifying possible
actions are not as readily available compared to other
countries. Yemen also scored low on having clearly iden-
tified places to find or ask for scientific evidence to in-
form the policymaking process (Table 3).
The case of Bahrain is an exact opposite of that of
Yemen. For instance, Bahrain scored highest compared
to other countries when it came to having contacts and
collaborative relations between policymakers and
researchers. In Bahrain, scientific evidence is reportedly
delivered at the right time. In fact, Bahrain had the high-
est score when it came to having policymakers request
scientific evidence for the policymaking process and also
using evidence whenever it is available and supplied to
them. Bahrain also had the highest score on delivery of
scientific evidence with information about quality and
Table 3 Comparing mean differences in factors influencing the health policymaking process and use of evidence in the policymaking across the study
countries (* indicates p-values <0.05, ** indicates p-values <0.001)
Overall Lebanon Pakistan Palestine Jordan Bahrain Sudan Yemen Oman Algeria Tunisia
N= 237 N=20 N=42 N=28 N=27 N=10 N=29 N=27 N=23 N=22 N=9
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Factors influencing the health policymaking process
1-Lack of coordination in
governmental/ministerial
relations across different
ministries (such as the Ministry
of Health, Ministry of Finance,
etc.) hindered the health
policymaking process.
3.86 (1.02) 4.20 (0.70) 3.93 (0.95) 3.79 (0.92) 4.04 (0.90) 3.2 (1.62) 4.24 (0.87)* 4.27 (0.78)* 3.09 (1.24)* 3.5 (0.96) 3.56 (1.01)
2-Lack of coordination in
government/ health provider
relations hindered the health
policymaking process.
3.62 (1.01) 3.55 (0.83) 3.76 (0.97) 3.82 (0.86) 4.04 (0.82)* 3.20 (1.40) 3.62 (1.12) 3.85 (0.78) 3.04 (1.19)* 3.45 (1.06) 3.00 (1.00)
3-Physician associations
exerted a strong influence
on the health policymaking
process.
2.6 (1.17) 3.35 (1.14) 2.88 (1.10) 2.29 (0.94) 3 (1.07) 2.78 (0.97) 2.48 (1.30) 1.63 (0.79)** 2.14 (1.11) 2.68 (1.25) 3.33 (0.87)*
4-Nursing associations exerted
a strong influence on the
health policymaking process.
2.22 (0.91) 2.25 (0.79) 2.26 (0.83) 2.18 (0.82) 2.56 (0.85)* 2.67 (0.71) 2.14 (0.95) 1.46 (0.71)** 2.15 (1.09) 2.43 (0.98) 2.88 (0.84)
5-Other types of health
professional associations




2.59 (1.07) 3.70 (0.80)** 2.67 (0.85) 2.11 (0.88)** 3 (1.18) 2.60 (0.70) 2.34 (0.90) 1.65 (0.85)** 2.19 (1.03) 3.14 (1.08)* 3.11 (0.93)
6-Private health providers
exerted a strong influence on
the health policymaking
process.
2.87 (1.08) 3.60 (1.10)** 2.67 (1.03) 2.96 (1.14) 3.3 (1.03)* 3.30 (0.82) 2.96 (1.02) 2.37 (1.04)* 2.3 (0.88)* 2.71 (1.01) 3.00 (1.00)
7-Private insurers exerted a
strong influence on the health
policymaking process.
2.42 (1.06) 2.80 (0.95) 2.45 (0.92) 2.32 (0.91) 2.44 (1.03) 2.56 (0.88) 3.1 (1.29)* 1.92 (1.02)* 1.96 (0.98)* 2.09 (1.14) 2.33 (0.87)
8-Values of governing parties
exerted a strong influence on
the health policymaking
process.
3.36 (1.22) 3.65 (1.39) 3.15 (1.04) 3.36 (1.22) 2.67 (1.8)* 3.70 (0.82) 4.00 (1.10)* 3.69 (1.09) 2.43 (1.29)* 3.5 (1.10) 4.22 (0.67)*
9-Public opinion exerted a
strong influence on the health
policymaking process.



















Table 3 Comparing mean differences in factors influencing the health policymaking process and use of evidence in the policymaking across the study
countries (* indicates p-values <0.05, ** indicates p-values <0.001)
Overall Lebanon Pakistan Palestine Jordan Bahrain Sudan Yemen Oman Algeria Tunisia
N= 237 N=20 N=42 N=28 N=27 N=10 N=29 N=27 N=23 N=22 N=9
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
10-Media exerted a strong
influence on the health
policymaking process.
3.21 (0.99) 3.40 (0.94) 2.95 (0.99) 2.79 (0.83) 3.67 (0.96)* 3.5 (1.18) 3.57 (1.10) 3.11 (0.93) 3.13 (1.14) 3.14 (0.77) 3.22 (0.67)
11-Research about problems
related to healthcare or health
systems exerted a strong
influence on the health
policymaking process.
3.17 (1.13) 3.30 (0.92) 3.12 (1.13) 2.79 (1.20) 2.96 (1.13) 3.5 (0.97) 3.54 (1.04) 2.81 (1.15) 3.78 (1.09)* 2.82 (1.18) 3.78 (0.83)
12-Limited public funding for
the health sector exerted a
strong influence on the health
policymaking process.
4.05 (1.10) 4.25 (0.91) 3.81 (1.38) 4.21 (0.79) 3.63 (1.25) 4.3 (1.25) 4.52 (0.68)* 4.3 (0.95) 3.78 (1.20) 3.86 (1.13) 4.00 (0.87)
13-Other countries’ health
policies exerted a strong
influence on the health
policymaking process.
3.14 (1.00) 2.85 (0.99) 2.76 (0.87)** 3.54 (0.92) 3.37 (0.74) 3.2 (1.03) 3.21 (1.15) 2.96 (0.96) 3.61 (0.94)* 2.95 (1.24) 3.00 (0.87)
14-Donor organizations
(e.g., United States Agency for
International Development
(USAID), United Nations,
World Bank, World Health
Organization (WHO)) exerted a
strong influence on the health
policymaking process.
3.83 (1.01) 4.00 (0.97) 3.86 (0.84) 4.32 (0.82) 4.00 (1.04) 3.2 (0.92) 4.07 (0.84) 4.04 (0.90) 3.43 (1.16) 3.14 (1.17)* 3.22 (1.09)
Use of evidence in the health policymaking process
1-I generally look and/or ask for
scientific evidence to support
my work in formulating and
implementing health policies.
4.28 (0.80) 4.70 (0.47)* 4.2 (0.93) 4.36 (0.68) 4.04 (0.76) 4.5 (0.53) 4.52 (0.51)* 3.96 (1.02) 4.48 (0.67) 3.95 (0.95) 4.33 (0.71)
2-I have access to health
research through an internet
connection at my organization.
3.94 (1.06) 3.75 (1.21) 3.98 (1.28) 4.18 (0.77) 3.81 (1.04) 4.4 (0.70) 4.21 (0.86) 3.63 (1.15) 3.74 (1.14) 3.68 (1.08) 4.44 (0.53)*




makers in my organization.



















Table 3 Comparing mean differences in factors influencing the health policymaking process and use of evidence in the policymaking across the study
countries (* indicates p-values <0.05, ** indicates p-values <0.001)
Overall Lebanon Pakistan Palestine Jordan Bahrain Sudan Yemen Oman Algeria Tunisia
N= 237 N=20 N=42 N=28 N=27 N=10 N=29 N=27 N=23 N=22 N=9
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
4-I participated in meetings
with researchers to identify
high-priority policy issues
for which research is needed
to inform how to address
these issues.
3.71 (1.06) 4.15 (0.49)* 3.63 (1.22) 3.82 (0.86) 3.37 (1.18) 4 (0.82) 4.07 (0.96) 3.31 (1.16) 3.65 (1.23) 3.41 (0.96) 4.44 (0.53)*
5-Health policymakers request
scientific evidence in the
policymaking process.
3.26 (1.09) 3.75 (1.07) 3.22 (1.13) 3.07 (1.09) 2.81 (1.11)* 4.2 (0.63)* 3.07 (1.00) 2.93 (1.21) 3.35 (0.89) 3.50 (1.01) 4.00 (0.87)*
6-The scientific evidence is
delivered at the right time.
2.77 (1.01) 2.7 (0.92) 2.9 (1.06) 2.75 (0.80) 2.56 (0.89) 3.6 (0.52)* 2.48 (0.98) 1.85 (0.77)** 3.00 (0.91) 3.52 (1.03)* 3.33 (1.00)
7-There are summaries of
evidence with messages that
specify possible actions about
health policies issues I
confronted in my organization.
2.96 (1.08) 3.1 (1.07) 3 (1.13) 3.14 (1.01) 2.7 (0.91) 3.1 (0.99) 2.93 (1.00) 2.41 (1.19)* 3.09 (1.20) 3.41 (1.01)* 2.89 (1.05)
8-The available scientific
evidence provides sufficient
information on the impacts,
costs and concrete benefits of
the studied or soon-to-
implement health policies.
3.04 (1.05) 3.15 (1.04) 2.83 (1.16) 3.00 (1.05) 2.69 (0.88) 3.6 (0.70)* 3.07 (1.10) 2.67 (1.07) 3 (1.02) 3.64 (0.79)* 3.89 (0.60)*
9-The available scientific
evidence is delivered with
information about its quality
and local applicability.
2.87 (1.05) 3.2 (1.06.) 2.83 (1.05) 2.96 (1.11) 2.62 (0.94) 3.5 (0.71)* 2.69 (1.11) 2.22 (0.97)* 2.95 (0.95) 3.23 (0.92) 3.63 (0.92)
10-There is a sufficient
quantity of health research
that may contribute to inform
the health policymaking/
decision making process.
3.02 (1.14) 3.25 (1.12) 3.05 (1.16) 3.04 (1.09) 2.58 (1.14) 3.1 (1.10) 3.1 (1.08) 2.68 (1.25) 2.78 (1.04) 3.5 (0.96)* 3.56 (1.33)
11-There are clearly identified
places to find or to ask for
scientific evidence that may
inform the health policymaking/
decision making process.
3.15 (1.09) 3.7 (0.92)* 3.24 (1.14) 3.21 (0.92) 2.69 (1.16) 3.9 (0.74)* 3.07 (1.03) 2.56 (0.89)* 2.7 (1.19) 3.64 (1.00)* 3.78 (0.67)*
12-Health policymakers use
scientific evidence in the
policymaking process
whenever it is available and
supplied to them.



















Table 3 Comparing mean differences in factors influencing the health policymaking process and use of evidence in the policymaking across the study
countries (* indicates p-values <0.05, ** indicates p-values <0.001)
Overall Lebanon Pakistan Palestine Jordan Bahrain Sudan Yemen Oman Algeria Tunisia
N= 237 N=20 N=42 N=28 N=27 N=10 N=29 N=27 N=23 N=22 N=9
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
13-I have received training to
acquire, assess the quality and
local applicability of scientific
evidence, and apply scientific
evidence in health
policymaking/decision making.
3.26 (1.28) 3.45 (1.40) 3.22 (1.17) 3.50 (1.00) 2.96 (1.37) 3.6 (1.43) 3.54 (1.32) 2.81 (1.42) 3 (1.35) 3.64 (1.09) 3 (1.32)
14-There is explicit budget or
funding for both research and evidence- informed health
policymaking within my
organization.
2.54 (1.13) 2.55 (1.19) 2.61 (1.16) 2.43 (1.17) 2.15 (0.86)* 2.9 (0.99) 2.34 (0.94) 2.44 (1.42) 2.7 (1.02) 3.05 (1.17) 2.67 (1.12)
15-There is an administrative
structure suitable to support
an evidence- informed health
policymaking process
(for example; a policy analysis
department or a decision
support unit, or the availability
of resources, incentives and
time for the use of scientific
evidence in health
policymaking).
2.62 (1.18) 2.45 (1.00) 3.18 (1.26)* 2.54 (1.11) 2 (0.83)* 3.3 (1.06) 2.66 (1.05) 2.33 (1.24) 2.26 (1.25) 2.86 (1.28) 2.89 (0.93)
16-The political actors related
with health (political parties,
ministers, parliament, other
ministries, etc.) value the use
of scientific evidence in the
policymaking process.
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clearly identified places to find or ask for evidence that
may inform the policymaking process. It was also
reported that the available evidence in Bahrain provides
sufficient information about impacts, costs and benefits
of soon-to-implement health policies (Table 3).
Tunisia also fared slightly better on use of evidence in
policymaking as compared to other countries. If we
compare Tunisia to other countries, it had the highest
mean score on access to health research through an
internet connection. Tunisia also had the highest score
on participation in meetings with researchers to identify
high-priority policy issues for which evidence is needed.
It is worth noting that Tunisia scored lower than Bah-
rain when it came to policymakers requesting evidence
for the policymaking process and having clearly identi-
fied places to ask for evidence. However, Tunisia scored
better than Bahrain on the item assessing whether the
available evidence in Bahrain provides sufficient infor-
mation about impacts, costs and benefits of soon-to-
implement health policies. Tunisia also fared better than
other countries with regard to having political actors
who value the use of scientific evidence in the policy-
making process (Table 3).
Comparing responses by respondent affiliation
Respondents were broken down into two groups, gov-
ernment affiliated (i.e. those working at the MOH) and
non-Government affiliated policymakers (i.e. NGOs,
professional associations and donor agencies). Differ-
ences between these two groups were assessed using a
t-test. Respondents working in the three non-Government
affiliated organizations were then compared to respon-
dents working at the MOH using ANOVA using Bonfer-
roni multiple F contrast. Only statistically significant
items are reported in Table 4.
Significant differences in responses on factors influen-
cing health policy formulation were observed between
respondents working in different areas. Results showed
that respondents working in non-Government affiliated
organizations had significantly higher agreement scores
than respondents working in the MOH regarding the
lack of coordination across different ministries and
health providers. Specifically, respondents from NGOs
had higher agreement scores when it came to these two
items compared to those from the MOH. Respondents
working in non-Government affiliated organizations per-
ceived greater pressure by private insurers on the health
policymaking process than their counterparts in the
MOH with higher agreement scores observed for
respondents from professional associations and NGOs
(Table 4). Public opinion, on the other hand, was per-
ceived to have a greater influence on the health policy-
making process by respondents in the MOH comparedrespondents from NGOs (Table 4). Significantly higher
agreement scores were also observed for respondents
from NGOs compared to those from donor agencies
regarding the influence of limited funding on the health
policymaking process (Table 4).
Significant differences were also observed between
respondents with regard to the use of evidence in health
policymaking. Respondents in NGOs reported signifi-
cantly higher means regarding the degree of contact and
collaboration between researchers and policymakers. On
the other hand, respondents in the professional associa-
tions reported higher agreement scores on the degree to
which policymakers request scientific evidence for the
policymaking process than those working in Donor
agencies (Table 4). Donor agencies reported significantly
lower agreement scores than professional associations
when it came to whether the existing evidence provides
sufficient information for soon-to-implement policies
(Table 4). Moreover, respondents from non-Government
affiliated organizations had significantly lower scores
than those in professional associations when asked
whether there is a sufficient quantity of health research
to inform the policymaking. Respondents from NGOs
had significantly lower scores when asked whether pol-
icymakers used evidence when it was made available to
them in the policymaking process. When asked whether
political actors value the use of scientific evidence,
respondents from the MOH had significantly higher
agreement scores than their counterparts (Table 4).
Examples on health policymaking in the MENA region
Formulation of a health policy where evidence was
available and used
In response to an open- ended question, the most fre-
quently mentioned examples of evidence being used in
the formulation of policies are: maternal and child health
(10%) and health strategic plan (10%). Some respondents
also cited vaccination schedules and accreditation strat-
egies as examples of health policies where evidence was
used (Table 5).
Formulation of a health policy where evidence was
available but not used
Respondents most frequently cited existing health
human resources strategies and needs in addition to the
evaluation of healthcare professionals’ training programs
(10%) as examples of policies not formulated using avail-
able evidence. For example, a policymaker from Lebanon
stated that “No policy [was formulated] at the educa-
tional level to control the high number of physicians due
to political reasons” and another policymaker from Paki-
stan stated that “population age and sex structure data is
not being used for developing human resources strat-
egies”. Furthermore, respondents frequently reported
Table 4 Comparing responses by respondent affiliation
Government Affiliated Non-Government affiliated
MOH Total† NGO Professional Association Donor Agency
N=161 N=75 N=37 N=19 N=19
Mean SD Mean SD Mean SD Mean SD Mean SD
Lack of coordination in
governmental/ministerial
relations across different
ministries (such as the Ministry
of Health, Ministry of Finance,
etc.) hindered the health
policymaking process.
1, 2 3.72 1.11 4.23 0.70 4.33 0.62 4.22 0.67 4.00 0.894
Lack of coordination in
government/ health provider
relations hindered the health
policymaking process.
1, 2 3.46 1.07 4.09 0.78 4.04 0.85 4.33 0.71 4.00 0.632
Private insurers exerted a
strong influence on the health
policymaking process.
1, 2, 3 2.29 1.07 3.00 0.88 2.88 0.91 3.38 0.74 3.00 0.894
Public opinion exerted a
strong influence on the health
policymaking process.
2 3.18 1.03 2.55 1.14 2.41 1.15 2.89 1.27 2.64 1.027
Limited health funding exerted
a strong influence on the
health policymaking process.
4 4.09 1.11 3.98 1.07 4.33 0.78 3.78 1.20 3.27 1.272




makers in my organization.
2 3.01 1.08 3.53 0.98 3.74 0.98 3.67 0.71 2.91 0.944
Health policymakers request
scientific evidence in the
policymaking process.
5 3.29 1.08 3.19 1.08 3.19 1.00 4.11 0.93 2.45 0.82
The available scientific
evidence provides sufficient
information on the impacts,
costs and concrete benefits of
the studied or soon-to-
implement health policies.
5 3.08 1.00 3.15 1.07 3.27 1.12 3.67 0.71 2.45 0.934
There is a sufficient quantity of
health research that may
contribute to inform the
health policymaking/decision
making process.
3 2.94 1.12 3.36 1.21 3.24 1.23 4 0.71 3.09 1.375
Health policymakers use
scientific evidence in the
policymaking process
whenever it is available and
supplied to them.
2 3.48 0.92 2.83 1.12 3.08 1.13 2.44 1.01 2.55 1.128
The political actors related
with health (political parties,
ministers, parliament, other
ministries, etc.) value the use
of scientific evidence in the
policymaking process.
1 2.96 1.04 2.55 1.19 2.70 1.30 2.33 1.11 2.36 1.03
† This column refers to the overall mean for Non-Government affiliated respondents. The T-test compares values in this column to that in the one with the
heading “Government affiliated – MOH”.
1 significant difference between Government affiliated (MOH) and non-Government affiliated (Total).
2 significant difference between MOH and NGO.
3 significant difference between MOH and Professional Association.
4 significant difference between NGO and Donor agencies.
5 significant difference between Professional Association and Donor agencies.
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Table 5 Examples of a health policy where evidence was available and had an important role, where evidence was
available but was not used, and where evidence was not available but was needed
Health policy where evidence was
available and had an important
role (n = 194)
Health policy where evidence was
available but was not used (n = 154)
Health policy where evidence was not
available but was needed (n= 141)
•Maternal and child health 20 (10%) •Human resources strategies and needs
and evaluation of training programs
15 (10%) •Implementation of chronic disease
screening and prevention programs
13 (9%)
•Health strategic plan 19 (10%) •Chronic disease screening, prevention,
and treatment





18 (9%) •Starting new medical centers,
programs and services
13 (8%) •Health strategic plan 12 (9%)
•Strategies on accreditation and
healthcare quality improvement
12 (6%) •Distribution of healthcare workers 11 (8%)
n= total number of responses to each question.
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vention and treatment were formulated without using
available evidence (9.7%). Respondents also frequently
indicated that the establishment of new healthcare cen-
ters was not based on feasibility studies and needs as-
sessment. For instance, a policymaker from Jordan
reported that “[the decision to] establish new health cen-
ters was influenced mainly by politicians” (Table 5).
Formulation of a health policy where evidence was needed
but not available across countries
In response to this open- ended question, respondents
most commonly indicated that evidence was needed on
how to locally apply programs related to chronic dis-
eases (9%) and accreditation (9%). Policymakers also
indicated that evidence is needed to substantiate na-
tional health strategic plans, as a policymaker from
Yemen stated “review and evaluation of the health sys-
tem based on [evidence from] country specific health
indicators [is needed]”. Another policymaker from Pales-
tine stated that “evaluation of financial policies and the
allocation of resources, and their impact on the health of
the population [is needed]”. They also reported that evi-
dence was needed to formulate policies on the distribu-
tion of healthcare workers. A policymaker from Jordan
stated that more local evidence is needed for the formu-
lation of “a policy that requires hospitals to apply ac-
creditation standards to improve their health care
services” and another policymaker from Lebanon stated
that “[locally applicable] patient satisfaction surveys [are
needed] for accreditation” (Table 5).
Barriers and facilitators to evidence- informed policies
and strategies to improve evidence to policy
In response to this question, respondents most fre-
quently reported lack of funding and investments in pri-
ority health research and in implementing evidence from
research in policy (16%) and lack of policy relevant re-
search (14%) as barriers to evidence- informed policies.
Other commonly mentioned barriers are over- ridingpolitical forces, corruption, and weak administrative
structure of policymaking, as well as lack of trained pol-
icymakers in accessing and using evidence (Table 6).
Commonly reported facilitators to evidence- informed
policies in the region include availability of policy rele-
vant health research (15%), easy access to information
(11%), availability of research funding (9%), support of
NGOs and international organizations (9%). Other fre-
quently mentioned facilitators are availability of research
centers, policymakers’ belief in the importance of health
systems evidence, availability of qualified health systems
researchers, communication and networking between
policymakers and researchers, wide dissemination of re-
search, and qualified policymakers (Table 6).
Respondents most frequently suggested building the
capacity of policymakers in locating proper information
and assessing the quality of research, its cost effective-
ness and local applicability (13%). Increasing funding
and investments in health research, improving dissemin-
ation and translation of research, and conducting rele-
vant health systems research to inform policy decisions
were also commonly mentioned suggestions for improv-
ing the use of research in policy. Other commonly
mentioned suggestions include establishing evidence-
to- policy decision support units to support policy-
makers in using research in policy, conducting
sensitization and awareness workshops on evidence-
informed policymaking, and enhancing contact and ex-
change between policymakers and researchers through
meetings and conferences and setting easy and effective
methods for communication and networking (Table 6).Policymakers’ training needs
Policymakers frequently listed the need for training on
how to develop health policies and use evidence in pol-
icymaking. Additional training areas include; training
on policy analysis, health economics, setting policy-
relevant research priorities, strategic planning, conduct-
ing operational health systems research, budgeting and
Table 6 Barriers and facilitators to evidence- informed policies and strategies to improve evidence to policy
Barriers to evidence-
informed policies (n = 446)
Facilitators to evidence-
informed policies (n = 145)
Strategies to improve
evidence to policy (n = 570)
•Lack of funding and
investment in priority health
research and in implementing
evidence from research in
policy
69 (16%) •Availability of policy relevant
health research
22 (15%) •Build the capacity of
policymakers in locating
proper information,
assessing the quality of
research, its cost effectiveness
and local applicability
75 (13%)
•Lack of policy relevant
research
62 (14%) •Easy access to information 16 (11%) •Increase funding and
investments in health research
7 (13%)
•Over- riding political forces 49 (11%) •Availability of research
funding
13 (9%) •Improve dissemination and
translation of research
59 (10%)




49 (11%) •Support of NGOs and
international organizations
that drive the use of research
in policymaking
13 (9%) •Conduct health systems
research to inform policy
44 (8%)
•Lack of trained policy makers
in accessing and using
evidence for policy making
43 (10%) •Availability of research centers 11 (8%) •Establish evidence- to- policy
decision support unit that
supports policy makers in
using research in policy.
41 (7%)
•Belief of policymakers in the
importance of evidence



















•Qualified policymakers 10 (7%)
n= total number of responses to each question, respondents listed up to three responses.
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leadership.
Discussion
There is very limited empirical work on evidence-
informed health policy and KT across multiple countries
in the Middle East region. By exploring policymakers’
views and practices regarding the use of health systems
evidence in 10 countries from the Middle East and
assessing contextual influences in health policymaking,
this study is an effort to provide essential knowledge that
can be used to design, promote and sustain effective KT
strategies that would strengthen health policymaking in
the region.
Policymaking is a complex process and our findings
show that a myriad of factors influence health policy-
making and often compete with health systems evidence.
Our findings show that factors such as values of govern-
ing parties, corruption, and weak administrative struc-
ture are among the many factors that play a major role
in the health policymaking process in the region. Mostcountries in the region fare poorly with corruption and
democracy indices, reflecting increased possibility for
policy formulation based on personal preference of gov-
ernment actors rather than evidence [30-32]. Literature
also argues that the existing political governance or the
ruling ideology in a given country can affect the applica-
tion of evidence [33]. Furthermore, the influence of the
political context and a corrupt and unstable political en-
vironment hinder the use of evidence in policymaking,
while pressure from stakeholders and public opinion
results in a culture conducive to the use of research
[9,19,34]. For instance, in Tunisia, values of governing
parties played a major role in the policymaking process.
The index for voice and accountability in Tunisia, which
captures the extent to which citizens are able to partici-
pate in selecting their government, is lower than that of
the region and of other LMICs [35], indicating that the
political regime rather than public opinion exerts a
strong influence on policymaking. On the other hand,
public opinion was stronger in Bahrain and weaker in
Pakistan than in other countries. Furthermore, the
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minimal in Palestine compared to other countries. This
is further supported by a high media freedom index in
Jordan and a low media freedom in Palestine [36].
The influence of private providers, insurers, and pro-
fessional associations was more pronounced in some
countries more than in others. For example, private
health providers and professional associations were more
influential in Lebanon, where they are the main provi-
ders of health services [37]. However, in Yemen the role
of nursing associations was weaker than in other coun-
tries and private insurers exerted a strong influence on
policymaking. It is important to bear in mind that both
Lebanon and Yemen have pluralistic health systems and
are classified as weak states in the sense that private sec-
tor has an upper hand.
Findings show that limited health funding also com-
petes with the use of research in the region. Resource
constraints, in terms of both human and fiscal resources,
were found to limit research utilization in LMICs [19].
Moreover, lack of coordination across various stake-
holders also plays a major role in health policymaking in
the region and was shown in the literature to decrease
the use of evidence into policy [9]. It was interesting to
note that countries of lower income status such as
Yemen and Jordan reported greater challenges with lack
of coordination across different stakeholders.
Our study shows that donor organizations exert a
strong influence on health policymaking processes in the
region. They can facilitate the use of evidence in devel-
oping countries; however, they may dictate their agendas
on recipient countries from the region and hinder
evidence- informed policies [9,38]. It is therefore crucial
that countries work with donor agencies to ensure that
research is translated into evidence and is of value to
policymakers in developing health policies.
Given the diversity of the policymakers who were sur-
veyed in this study and the different contexts in which
they worked, it is striking to find that common influen-
cing factors were identified. Policymakers outside the
government play an important role in the policymaking
process and may influence the policymaking process.
This may be due to the fact that policymakers outside
the government are often more affected by decisions
made and thus they try their best to influence the policy-
making process to influence the decisions being made to
their advantage [39]. This being said, it is also important
to note that there are key contextual factors that are dif-
ferent in terms of their influences in these countries.
These differences in context would suggest that different
strategies can be devised for countries to translate health
systems evidence into policy [1]. Understanding the con-
text in which users of evidence operate in provides valu-
able insights into effective methods to support KT [19].Our findings show that policymakers recognize the
benefits of integrating health systems evidence in the
policymaking process. Policymakers from the region use
globally produced evidence in formulating health pol-
icies such as vaccination schedules and accreditation
strategies. However, policymakers did not use evidence
when other contextual forces including politics com-
peted with evidence such as in the reported examples
related to establishing new healthcare centers and deter-
mining health human resources strategies. This means
that even when relevant research exists, it can be over-
looked due to other factors and constraints that could
be more relevant for the decision making process and
that different contexts can lead to different utilization of
the same evidence. While global knowledge on certain
areas is available, study findings also show that there is a
need for locally produced context- specific evidence to
formulate policies on the distribution of healthcare
workers as well as the application of chronic diseases
and accreditation programs. As literature indicates, con-
textualizing evidence for effective policymaking is a key
challenge for health systems [40].
Findings from this study corroborate those previously
reported from semi-structured interviews conducted
with health care managers and policymakers from
Canada and the UK [10] and a survey of policymakers
and researchers was in Australia [2] as well as interviews
with policymakers from LMICs [19]. Similar to findings
from the region, policymakers from Canada and the UK
also pointed out that many factors other than research
evidence influenced policymaking, including financial
sustainability, local competition, pressure from stake-
holders and public opinion [10]. Furthermore, the use of
research evidence in policymaking processes, as reported
by policymakers, is comparable to those from Canada,
the UK [10], and Australia [2], whereby the majority
reported using evidence to inform policy content. While
policymakers from Australia and LMICs placed high
value on the use of research evidence in policymaking
[2,19], findings from this study indicated that limited
value given to research hindered evidence- informed
policymaking. The lack in policymakers’ technical cap-
acity to access and use research evidence, the need for
more contact and exchange between researchers and
policymakers as well as for more policy- relevant re-
search was also emphasized by policymakers in previous
studies [2,19].
Strengths and limitations
Our study has three main strengths: (1) it is among the
very few studies (if not the first) to explore the views
and practices of policymakers in 10 countries in the
EMR on the use of health systems evidence including
contextual influences in policymaking; (2) we sampled a
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mental entities, professional associations, private sector
and civil society representatives, donor agencies across
the ten countries; and (3) we used combined quantitative
and qualitative research data analysis methods. Our
study has a few limitations. It presents results on the use
of evidence in policy based on the perception of a pur-
posefully selected sample of policymakers. Hence, find-
ings might not be representative of all policymakers in
the region and results may not be generalizable across
the region. This study was not intended to include a rep-
resentative sample since it is difficult to obtain given the
mix of policymakers and the diversity of contexts in
which health policy decision- making occurs. It is worth
noting that there was a variable response between differ-
ent categories of policymakers within each country
whereby the largest group of respondents in most coun-
tries were policymakers affiliated with the MOH. More-
over, there was a variable response rate across countries
(range: 9–42 respondents per country). The varying de-
gree in responses in some countries may be explained by
the fact that more positions in the sampling frame are
filled in some countries compared to others. This may
be due to larger health systems including reform initia-
tives, larger populations, etc. For example, in Pakistan
13 positions were filled for national NGOs compared to
two in most countries. In Yemen, eight positions were
filled by managers of pharmacists’ associations compared
to one in other countries. Despite this, we achieved an
average of 23.7 respondents. Furthermore, given the na-
ture of policymakers’ work (i.e. busy time schedule, last
minute meetings, etc), the response rate of 56.3%
obtained in this study is considered acceptable. The re-
sponse rate is also comparable to response rates on sur-
veying policymakers, stakeholders, and researchers from
the region: researchers from the region: 56% [41], 64.6%
[28], and 83 policymakers from six countries [19].
In addition to the above, it was difficult to discuss
the different contextual factors that determine country
specific results within the data available. This may be
due to the fact that context mapping has not yet been
conducted in the region to identify specific factors and
indicators that reflect use of evidence in policymaking.
Country specific factors may have had a major role in
determining the findings in the qualitative survey com-
ponent and the section on comparing responses by
study country. Despite the fact that such factors are
important, discussing them is beyond the context of
this specific paper. Discussing the context-specific
issues that govern how policies are made and how evi-
dence is used should be given justice by making them
the focus of future country case studies that include
additional data on the policymaking environment of
study countries.Another limitation of this study is the social desirabil-
ity bias inherent with self- reported questionnaires.
Respondents may have provided the answers they con-
sidered desirable by the investigators. Responses may
present either true beliefs or perceptions of what
respondents thought researchers wanted to hear, or a
combination of both. However, it can be safely assumed
that the results are not overly inflated because of the
positive nature of almost all the questions. Furthermore,
self- reports of current behavior provide clear information
on where improvements should be implemented [42].
Potential strategies to improve the use of
research evidence
In order to strengthen the use of evidence in policies,
efforts should be targeted to promote a supportive cli-
mate for evidence- informed policies, produce, package,
and disseminate evidence, facilitate users’ pull, and pro-
mote exchange between researchers and policymakers
[6]. Based on study findings, potential strategies for in-
creasing the use of health systems evidence into health
policies at each of these levels in the EMR are proposed.
Increasing funding and investments to support evidence to
policy activities
Policymakers from the region suggested increasing
health research funding to improve evidence- informed
health policymaking. Improving research infrastructure
and funding is important to generate policy- relevant
evidence for policymaking [2]. Several activities can be
employed in this regard, such as building the
organizational culture for health systems research and
providing incentives and resources for policymakers and
researchers to engage in evidence- to- policy activities
[2,19]. In a study about KT in developing countries, it
was found that the application of research might be hin-
dered when there is a lack of financial resources, while
pressure from stakeholders and peers, and a climate
conducive to the use of research can contribute to the
success of KT activities [22].
Producing policy- relevant research evidence and improving
packaging and dissemination of research
Study findings show that there is a need to enhance the
production of policy- relevant research and to improve
the ways with which researchers present and disseminate
evidence to policymakers. In order to increase the rele-
vance of research to policy, it is important that policy-
makers identify and communicate gaps in knowledge
and policy priorities for research to researchers [2]. Fur-
thermore, researchers should enhance their understand-
ing of the policymaking context, focus on policy-
relevant concerns, and improve the presentation of re-
search results and implications [2]. The production of
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orities is an important KT strategy that can be employed
in the region. A recent regional study identified policy
relevant research priorities for health financing, human
resources for health and the role of the non-state sector.
So far, little progress has been made in generating evi-
dence on these priority areas [3].
Policymakers from the region also indicated that the
available research was not delivered at the right time
and that it lacked information on its quality and local
applicability and actionable messages. Literature also
shows that timeliness and relevance of research and the
inclusion of a summary with clear recommendations fa-
cilitate the use of evidence in policymaking [9,10,19].
The establishment of clearinghouse mechanisms, evi-
dence to policy support units, national databases, or in-
stitutional mechanisms in academic institutions or at
Ministries of Health were also suggested to improve re-
search packaging and targeted dissemination to policy-
makers in the region.
Building the technical capacity of policymakers
It was discussed earlier that policymakers’ lack of train-
ing and awareness on using evidence was a major bar-
rier to using evidence in health policymaking in the
region. It is worth noting that there are no established
training and education programs to date that target pol-
icymakers in the Middle East region. As such, many
policymakers might not have the skills and the scien-
tific, professional or policymaking background. Building
the capacity of policymakers in the region to locate the
proper information and assess the quality of research,
its cost effectiveness and local applicability was sug-
gested by respondents to improve evidence- informed
policymaking. Literature shows that lack of policy-
makers’ skills and expertise decreased the prospects for
research use and that training can affect their decision
making and the quality of decisions taken [10]. Various
studies support a greater emphasis on training of pol-
icymakers since such training would foster a more posi-
tive attitude towards the use of research findings and
boost receptivity [43]. In countries where research and
policy connections are strongest, some of the senior
administrators have had research experience or interest
as part of their prior education [43].
Increasing communication and exchange between
policymakers and researchers
Findings clearly indicate that there is a need to improve
communication and exchange between researchers and
health policymakers in the region. In fact, less than half
of the respondents (43.1%) indicated having close collab-
orative relationships with researchers. Two- way commu-
nication and exchange can facilitate a mutual understandingof policy questions and the kind of knowledge that is needed
to answer these questions. It can also inform researchers
on the decision making process and on what policymakers
consider as timely, relevant, or good quality research [9].
Policy dialogue meetings, informal opportunities for inter-
action, joint workshops for policymakers and researchers,
establishing fora for knowledge sharing, and actively in-
volving policymakers at various stages of the research
process are among the most important strategies for in-
creasing the prospects of research use [2,9,10,19].
Literature also suggests that the interaction between
researchers and policymakers and the existence of an ac-
countable “receptor” function in the government would
favor the use of health services research in policymaking
[44].
Researchers and policymakers in the region should
create more opportunities for interaction. Moreover, re-
search funders need to emphasize that researchers
should work in partnership with policymakers to ask
and answer relevant policy concerns.
Conclusion
Health policymakers in several Middle Eastern countries
recognize the importance of using health systems evi-
dence in health policymaking. Our findings show that
there are no negative attitudes by policymakers toward
research evidence, its use, and benefits in the policy-
making process. Strengthening health policymaking by
using effective KT strategies requires serious efforts by
both policymakers and researchers. This study identified
barriers and facilitators for the use of health systems evi-
dence in policymaking and it is hoped that the findings
would prompt policymakers and researchers to start a
dialogue and cooperative relationships.
Our study shows that fostering evidence- informed
policymaking requires a clear understanding of the na-
tional contexts in which policy decisions are made. The
process through which evidence from health systems re-
search is utilized in policymaking is complex and multi-
dimensional. To make significant impact on policy
decisions, one must reflect a deeper understanding of
the context in which these decisions are made.
Future studies from the region should also focus on
investigating how policymakers “use” or “not use” health
systems evidence in relation to certain policy issues, and
how evidence interacts with context. In addition, future re-
search should focus on assessing policymaking organization
capacity to acquire, assess, adapt and apply research evi-
dence. Future studies could also focus on exploring the link
between the use of evidence and health status indicators in
a given country.
Lastly, our study findings are important and timely in
light of the changes that are unfolding in some Arab
countries. Findings can provide some insights in setting
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strengthen health systems and policy. Also, they can
provide a baseline to undertake an analysis of the under-
lying transformations and their respective health policy
implications including the way evidence will be used in
the future into policy decisions. Study findings can also
help inform and direct future plans and activities for the
EVIPNet EMR and Middle East and North Africa
(MENA) Health Policy Forum, in addition to being use-
ful for countries that host or are planning to host KT
platforms in the region.
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